Compare · 2 funds side by side · dividends reinvested

CURE and SPXL

CUREDirexion×SPXLDirexion×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$21,895SPXL · best of the two

02 / 04

CURE and SPXL, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Direxion Daily Healthcare Bull 3X ETFLeveraged · 3x0.94%0.76%+49.8%+82.5%+31.0%+7.8%−31.1%48.0%$200M1.5

Direxion Daily S&P 500 Bull 3X SharesLeveraged · 3x0.95%0.54%+22.5%+20.6%+59.2%+17.0%−26.8%38.3%$6.5B1.5

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 3, 2026 · returns include dividends · since: CURE 2011 · SPXL 2008

Head to Head

Swap sides Versus in desk

Head to Head

Direxion Daily Healthcare Bull 3X ETF · $200M$14,551

CURE

SPXL

Direxion Daily S&P 500 Bull 3X Shares · $6.5B$21,895

$10,000 five years ago, dividends reinvested · they hold 2.2% in common

CUREMeasureSPXL

+49.8%Year to dateJan 1 → Nov 3+22.5%

+82.5%1 yearTotal return+20.6%

+31.0%3 years · per year$10,000 became $22,495 · $40,354+59.2%

+7.8%5 years · per year$10,000 became $14,551 · $21,895+17.0%

0.94%Expense ratio$94 · $95 a year on $10k · lower is better0.95%

0.76%Trailing 12-mo yield$76 · $54 a year on $10k0.54%

−31.1%Worst dropSmaller is better−26.8%

48.0%VolatilityLower is calmer38.3%

CURESPXL Winner of the row, in its colourEach row: the bigger of the two fills its side

4–4Level

End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

CURE vs SPXL: Top 5 Holdings

Today

CURE

9.4%in top 5

SPXL

in top 55.8%

CUREStockSPXL

3.5%LLYnot top 5

2.0%JNJnot top 5

not top 5AAPL1.6%

not top 5NVDA1.6%

1.6%ABBVnot top 5

not top 5MSFT1.2%

1.1%MRKnot top 5

1.1%UNHnot top 5

not top 5AMZN0.8%

not top 5GOOGL0.5%

Held in common2.2%

End-of-day Nov 3, 2026 · share of each fund

CURE vs SPXL Returns, Every Period

DirexionCURE

+7.8%

5 years, per year

SPXLDirexion

+17.0%

5 years, per year

CURESPXLFaded: behind in that period

2–2Level

End-of-day Nov 3, 2026 · dividends in · faded = behind in that period

CURE vs SPXL

YTD

DirexionCURE

+49.8%

SPXLDirexion

+22.5%

+49.8%Year to date+22.5%

−31.1%Worst drop · 1Y−26.8%

48.0%Volatility · 1Y38.3%

0.8%Yield0.5%

$200MAssets$6.5B

2–2level

End-of-day Nov 3, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: CURE, SPXL

Today

0.94%lowest, CURE

FundExpense ratioFee$10k

CURE0.94%$94

SPXL0.95%$95

End-of-day Nov 3, 2026 · fee on $10,000 a year

Yields: CURE, SPXL

0.76%highest, CURE

FundTrailing yieldYield$10k

CURE0.76%$76

SPXL0.54%$54

End-of-day Nov 3, 2026 · trailing 12-month yield

Income After Fees on $10,000

−$18most kept, CURE

CURE$76 − $94 = −$18

SPXL$54 − $95 = −$41

KeptFee

End-of-day Nov 3, 2026 · yield in dollars minus the fee

Overlap: CURE, SPXL

Today

2.2%most shared, CURE and SPXL

CURESPXL

CURE—2.2%

SPXL2.2%—

End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+82.5%CURE, at 48.0% volatility

SPXLWorst drop−26.8%38.3% vol

CUREWorst drop−31.1%48.0% vol

End-of-day Nov 3, 2026 · up and left is better

Paid More vs Made More

YTD

CURESPXL

+49.8%Year to date+22.5%

0.8%Yield0.5%

+82.5%Past year+20.6%

0.94%Fee0.95%

4–0CURE wins

End-of-day Nov 3, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+32.8%

VIGVanguard

+14.0%

+32.8%Year to date+14.0%

3.0%Yield1.5%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 3, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+7.5%

JEPIJ.P. Morgan

+7.0%

+7.5%Year to date+7.0%

12.3%Yield8.0%

$41.8BAssets$46.0B

2–0JEPQ wins

End-of-day Nov 3, 2026

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

+11.5%Year to date+11.5%

1.0%Yield1.0%

$185BAssets$798B

0–0level

End-of-day Nov 3, 2026